ReviewFluids and barriers of the CNS2025
Functions of the basal lamina and ApoE in cerebral amyloid angiopathy.
Review in Fluids and barriers of the CNS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder marked by the deposition of amyloid-beta (Aβ) peptides within the walls of small- and medium-sized cerebral vessels, including arteries and capillaries but rarely veins. This vascular amyloid burden compromises vessel integrity, causes hemorrhages, and contributes to cognitive decline. Efficient Aβ clearance is critical for preventing its pathological accumulation. Thus, understanding the molecular players within the vascular microenvironment is essential. Laminin, a key glycoprotein of the vascular basal lamina (BL), is fundamental to maintaining structural stability of the vessels and regulating interactions among endothelial cells, pericytes, and the extracellular matrix. However, controversial findings exist on how laminin regulates Aβ aggregation and clearance, with both inhibitory and facilitative effects reported. Genetic variations in laminin subunits, their cell-specific expression pattern, and BL remodeling during CAA further complicate this relationship. This review synthesizes current knowledge on vascular Aβ deposition and elimination in CAA, with a particular focus on the critical roles of the BL/laminin and ApoE in shaping the perivascular microenvironment. First, we introduce Aβ processing relevant to CAA and the mechanisms of Aβ clearance in the CNS. Next, laminin-Aβ interactions and their functions in Aβ clearance are summarized. Thirdly, laminin changes and BL remodeling in CAA are discussed. Finally, we discuss the knowledge gap in the field and fundamental questions that need to be answered in future research. Defining the functions of the BL and ApoE within the pathological context of Aβ-rich vasculature may yield new insights into CAA pathogenesis and reveal therapeutic targets to limit vascular amyloid accumulation. Our goal is to provide a concise review on this matter in order to facilitate new hypotheses in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.